The Research, Scholarship, and Artistic Achievement Awards nomination deadline has been extended to May 31, 2024. Click here for more information.

Peptide Compositions and Methods to Treat Herpesvirus Infections


Tulane University is actively seeking commercial entities to further develop and commercialize peptide compositions to prevent and treat herpesvirus infections in humans and animals.


Peptide compositions may be used to prevent and treat herpesvirus infections, including Herpes Simplex Virus-1 and Human Cytomegalovirus. Peptides may be used alone or in conjunction with other antiviral agents. Peptides inhibit viral entry, thus preventing lifelong latency of herpesviruses. Peptides may be used in subjects that are immunocompromised and thus not suitable for current antiviral treatments. Peptides may be used in pregnant women to inhibit vertical transmission of herpesviruses from mother to fetus.

Current Work

This technology has been tested extensively in the lab with success using several different peptide compositions.

Available For

Exclusive License in a Field
Non-exclusive License
Scientific Collaboration

For more information, please contact: